Anti-amyloid therapies work for Alzheimer's disease

被引：0

作者：

Hardy, John ^{[1
,2
,3
,4
,5
,6
]}

机构：

[1] UCL Inst Neurol, Reta Lilla Weston Res Labs, London WC1N 3BG, England

[2] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England

[3] UCL Inst Neurol, Dementia Res Inst, London WC1N 3BG, England

[4] UCL Inst Neurol, Reta Lilla Weston Res Labs, Queen Sq, London WC1N 3BG, England

[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England

[6] UCL Inst Neurol, Dementia Res Inst, Queen Sq, London WC1N 3BG, England

来源：

BRAIN COMMUNICATIONS | 2023年 / 5卷 / 04期

关键词：

TAU;

D O I：

10.1093/braincomms/fcad204

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

下载

页数：2

共 50 条

[41] Anti-amyloid agents for treating incipient Alzheimer's disease: a new hope?
Loureiro, Julia C.
Silva, Luiz Fernando A. L.
Pais, Marcos, V
Forlenza, Orestes, V
BRAZILIAN JOURNAL OF PSYCHIATRY, 2022, 44 (04) : 368 - 369
[42] Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
Michael A Castello
John David Jeppson
Salvador Soriano
BMC Neurology, 14
[43] A Multilevel Study of Eupatorin and Scutellarein as Anti-Amyloid Agents in Alzheimer′s Disease
Rizou, Aikaterini E. I.
Nasi, Georgia I.
Paikopoulos, Yiorgos
Bezantakou, Dimitra S.
Vraila, Konstantina D.
Spatharas, Panagiotis M.
Dimaki, Virginia D.
Papandreou, Nikos C.
Lamari, Fotini N.
Chondrogianni, Niki
Iconomidou, Vassiliki A.
BIOMEDICINES, 2023, 11 (05)
[44] Monoclonal anti-amyloid antibodies for the treatment of Alzheimer's disease and the hesitant geriatrician
Chin, Nathaniel A.
Widera, Eric
Brangman, Sharon A.
Karlawish, Jason
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (02) : 643 - 645
[45] Lecanamab Ushers in a New Era of Anti-Amyloid Therapy for Alzheimer's Disease
Musiek, Erik S. S.
McDade, Eric
Holtzman, David M. M.
ANNALS OF NEUROLOGY, 2023, 93 (05) : 877 - 880
[46] Alzheimer disease: Anti-amyloid vaccination reduces neurite abnormalities
Jones N.
Nature Reviews Neurology, 2010, 6 (6) : 297 - 297
[47] Transgenic amyloid precursor protein mouse models of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti-amyloid therapies
Morgan, David G.
Lamb, Bruce T.
ALZHEIMERS & DEMENTIA, 2023,
[48] FDA approves second anti-amyloid antibody for Alzheimer disease
Asher Mullard
Nature Reviews Drug Discovery, 2023, 22 : 89 - 89
[49] FDA approves third anti-amyloid antibody for Alzheimer disease
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 571 - 571
[50] FDA approves second anti-amyloid antibody for Alzheimer disease
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (02) : 89 - 89

← 1 2 3 4 5 →